Stock analysts at StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Stock Down 1.2 %
NASDAQ RKDA opened at $5.01 on Friday. The firm has a market cap of $6.81 million, a P/E ratio of -1.17 and a beta of 0.90. Arcadia Biosciences has a 52-week low of $1.85 and a 52-week high of $10.31. The business’s 50-day moving average price is $4.80 and its 200 day moving average price is $3.67.
About Arcadia Biosciences
Featured Stories
- Five stocks we like better than Arcadia Biosciences
- Investing in Commodities: What Are They? How to Invest in Them
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.